Human immunodeficiency virus (HIV) phenotype and interleukin- 2/interleukin-10 ratio are associated markers of protection and progression in HIV infection

Blood

Volumn 88, Issue 2, 1996, Pages 574-579

  Clerici, Mario ^a   Balotta, Claudia ^b   Salvaggio, Antonino ^b   Riva, Chiara ^b   Trabattoni, Daria ^b   Papagno, Laura ^b   Berlusconi, Alberto ^b   Rusconi, Stefano ^b   Villa, Maria Luisa ^b   Moroni, Mauro ^b   Galli, Massimo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2;

ADULT; ARTICLE; CELL PROTECTION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CYTOPATHOLOGY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; VIROLOGY; VIRUS REPLICATION;

EID: 8944257611     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.2.574.bloodjournal882574     Document Type: Article

References (32)

1. Miedema F, Meyaard L, Koot M, Klein MR, Roos MTL, Groenik M, Fouchier RAM, Van'T Wout AB, Tersmette M, Schellers PTA, Schuitemeker H: Changing virus-host interactions in the course of HIV infection. Immunol Rev 140:35, 1994
2. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183, 1993
3. Asijo B, Morfeldt-Manson L, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyo EM: Replicative capacity of human immunodeficiency virus from patients with varying severity of infection. Lancet 2:660, 1986
4. Schuitemaker H, Koot M, Koostra NA: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic virus population. J Virol 66:1354, 1992
5. Cheng-Mayer C, Seto D, Tateno M, Levy JA: Biologic features of HFV-1 that correlate with virulence in the host. Science 240:81, 1988
6. Tersmette M, Lange JMA, De Geode REY: Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1:983, 1989
7. Koot M, Keet IPM, Vos AHV, de Goede REY, Roos MThL, Coutinho RA, Miedema F, Schellekens PThA, Tersmette M: Prognostic value of human immunodeficiency virus type 1 biological phenotype for rate of CD 4 depletion and progression to AIDS. Ann Intern Med 118:681, 1993
8. Blatt SP, Hendrix CW, Butzin CA, Freeman TM, Ward WW, Hensley RE, Melcher GP, Donovan DJ, Boswell RN: Delayed type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med 119:177, 1993
9. Markowitz N, Hansen NI, Wilcosky TC, Hopeswell PC, Glassroth J, Kvale PA, Mangura BT, Osmond D, Wallace JM, Rosen MJ, Reichman LP: Tubercolin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 119:185, 1993
10. Clerici M, Shearer GM: A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107, 1993
11. Clerici M, Shearer GM: The Th1/Th2 theory of HIV infection: New insights. Immunol Today 15:575, 1994
12. Barcellini W, Rizzardi GP. Borghi MO, Meroni PL: TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 8:757, 1994
13. Koot M, Schellekens PTHA, Mulder JWH: HIV-1 biological phenotype in long-term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 6:49, 1992
14. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM: Changes in interleukin 2 and interleukin 4 production in asymptomatic, HIV-seropositive individuals. J Clin Invest 91:759, 1993
15. Dolan MJ, Clerici M, Blatt SP, Hendrix CW, Melcher GP, Boswell RN, Freeman TM, Ward W, Hensley R, Shearer GM: In vitro T cell function, delayed type hypersensitivity skin testing, and CD4 T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 172:79, 1995
16. Hollander M, Wolfe DA: Nonparametric Statistical Methods, New York, NY, Wiley, 1973, p 68, 115, and 194
17. Kendall M, Dickinson GJ: Rank Correlation Methods (ed 5). London, UK, Edward Arnold, 1990, p 113
18. Ho Dh, Moudgil T, Masud A: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321:1621, 1989
19. Coombs RW, Collier AC, Allain J-P, Nikora B, Leuther M, Gjerset GF, Corey L: Plasma viremia in human immunodeficiency virus infection. N Engl J Med 321:1626, 1989
20. Schwartz D, Sharma U, Busch M, Weinhold K, Mattews T, Lieberman J, Birx D, Fardazegan H, Margolick J, Quinn T, Davis B, Basagra O, Pomerantz R, Viscidi R: Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV - long term survivor. AIDS Res Hum Retroviruses 10:1703, 1994
21. Cao Y, Qin L, Zhang L, Safrit J, Ho DD: Virologic and immunologic characterization of long-term survivors of HIV type 1 infection. N Engl J Med 332:201, 1995
22. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orestein JM, Fox C, Schrager LK, Margolick JB, Buchbinder S, Giorgi JV, Fauci AS: Studies in subjects with long-term nonprogressive HIV infection. N Engl J Med 332:209, 1995
23. Garbuglia AR, Salvi R, Di Caro A, Montella F, Di Sora F, Recchia O, Delfini C, Benedetto A: Peripheral lymphocytes of clinical non-progressor patients harbor inactive and uninducible HIV proviruses. J Med Virol 46:116, 1995
24. Connor RI, Mohri H, Ho DD: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 67:1772, 1993
25. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM. A strategy for prophylactic vaccination against HIV. Science 260:1270, 1993
26. Clerici M, Balotta C, Meroni L, Ferrario E, Riva C, Trabattoni D, Ridolfo AL, Villa ML, Shearer GM, Moroni M, Galli M: Type 1 cytokine production and low prevalence of viral isolation correlate with long term non-progression in HIV infection. AIDS Res Hum Retroviruses (in press)
27. Rinaldo C, Huang X-L, Fan Z, Ding M, Beltz L, Logar A, Panicali D, Mazzara G, Liebman J, Cottril M, Gupta F: High levels of anti HIV-1 memory cytotoxic T lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long term nonprogressors. J Virol 69:5838, 1995
28. Roilides E, Clerici M, DePalma L, Rubin M, Pizzo PA, Shearer GM: T helper cell responses in children infected with human immunodeficiency virus type 1. J Pediatrics 118:724, 1991
29. Israel-Biet D, Labrousse F, Tourani J-M, Sors H, Andrieu JM, Even P: Elevation of IgE in HIV-infected subjects: A marker of poor prognosis. J Allergy Clin Immunol 89:68, 1992
30. Vigano' A, Crupi L, Principi N, Onorato J, Zuccotti GV, Salvaggio A: Elevation of IgE in HIV-infected children and its correlation with the progression of the disease. J Allergy Clin Immunol 95:627, 1995
31. Smith KJ, Skelton HG, Drabick JJ, McCarthy WF, Ledsky R, Wagner KF: Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease. Arch Dermatol 130:119, 1994
32. Caterino-de-Araujo A: HIV-1 infection and eosinophilia. Immunol Today 15:498, 1994